Urologic Health

Urologic Health Inc. is a medical device company pioneering non-invasive urodynamics to transform bladder function assessment. The company's flagship niu™ System is a catheter-free platform that utilizes AI-driven analytics to capture clinically meaningful bladder activity data, addressing a major diagnostic barrier in urological care. By providing a painless and repeatable alternative to traditional invasive catheterization, the system supports longitudinal monitoring for conditions such as overactive bladder, urinary retention, and incontinence. Founded through the MEDX Xelerator (now EdgeLabs) and backed by Edge Medical Ventures, the company maintains engineering operations in Israel and its commercial headquarters in Jersey City, New Jersey. The company recently secured $11 million in seed funding to advance its FDA 510(k) regulatory pathway and support its initial U.S. commercial launch.